Evaluation of TGF-α and EGFR expression in oral leukoplakia and oral submucous fibrosis by quantitative immunohistochemistry

Mythily Srinivasan, Scott D. Jewell

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Objective: Oral leukoplakia (OL) and oral submucous fibrosis (OSMF) are clinically distinct preneoplastic states that precede the development of oral squamous cell carcinoma. Recently, attempts are being made to identify specific molecular event(s) as prognostic markers to identify oral precancerous lesions with higher malignant potential. The goal of the present study was to evaluate the expression of EGFR and its ligand TGF-α in OL with dysplasia and OSMF as intermediate markers of malignancy by quantitative immunohistochemistry. Methods: Oral tissues were stained with monoclonal antibodies to TGF-α and EGFR. The results were analyzed with Photoquant image analysis software. Results: The expression of TGF-α and EGFR was upregulated in OL, OSMF and oral squamous cell carcinomas relative to normal oral mucosa. The area and intensity of staining of TGF-α in the proliferative layers (stratum germinativum) increased linearly in OL with mild, moderate and severe dysplasia as compared to control mucosa (p <0.05). EGFR levels increased linearly in the stratum spinosum in OL with increasing degrees of dysplasia (p <0.05). In general, the expression of both proteins in OSMF was similar to that in OL with moderate dysplasia. Conclusions: EGFR and TGF-α represent early markers of malignancy in OL with dysplasia. Quantitative measurement of these proteins may provide intermediate endpoints in prospective chemopreventive trials.

Original languageEnglish (US)
Pages (from-to)284-292
Number of pages9
JournalOncology
Volume61
Issue number4
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Oral Submucous Fibrosis
Oral Leukoplakia
Immunohistochemistry
Squamous Cell Carcinoma
Mouth Mucosa
Neoplasms
Mucous Membrane
Proteins
Software
Monoclonal Antibodies
Staining and Labeling
Ligands

Keywords

  • EGFR
  • Oral epithelial dysplasia
  • Oral submucous fibrosis
  • Quantitative image analysis
  • TGF-α

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Evaluation of TGF-α and EGFR expression in oral leukoplakia and oral submucous fibrosis by quantitative immunohistochemistry. / Srinivasan, Mythily; Jewell, Scott D.

In: Oncology, Vol. 61, No. 4, 2001, p. 284-292.

Research output: Contribution to journalArticle

@article{c07b5264b2104e03af3b706e6d8805d5,
title = "Evaluation of TGF-α and EGFR expression in oral leukoplakia and oral submucous fibrosis by quantitative immunohistochemistry",
abstract = "Objective: Oral leukoplakia (OL) and oral submucous fibrosis (OSMF) are clinically distinct preneoplastic states that precede the development of oral squamous cell carcinoma. Recently, attempts are being made to identify specific molecular event(s) as prognostic markers to identify oral precancerous lesions with higher malignant potential. The goal of the present study was to evaluate the expression of EGFR and its ligand TGF-α in OL with dysplasia and OSMF as intermediate markers of malignancy by quantitative immunohistochemistry. Methods: Oral tissues were stained with monoclonal antibodies to TGF-α and EGFR. The results were analyzed with Photoquant image analysis software. Results: The expression of TGF-α and EGFR was upregulated in OL, OSMF and oral squamous cell carcinomas relative to normal oral mucosa. The area and intensity of staining of TGF-α in the proliferative layers (stratum germinativum) increased linearly in OL with mild, moderate and severe dysplasia as compared to control mucosa (p <0.05). EGFR levels increased linearly in the stratum spinosum in OL with increasing degrees of dysplasia (p <0.05). In general, the expression of both proteins in OSMF was similar to that in OL with moderate dysplasia. Conclusions: EGFR and TGF-α represent early markers of malignancy in OL with dysplasia. Quantitative measurement of these proteins may provide intermediate endpoints in prospective chemopreventive trials.",
keywords = "EGFR, Oral epithelial dysplasia, Oral submucous fibrosis, Quantitative image analysis, TGF-α",
author = "Mythily Srinivasan and Jewell, {Scott D.}",
year = "2001",
doi = "10.1159/000055335",
language = "English (US)",
volume = "61",
pages = "284--292",
journal = "Oncology",
issn = "0890-9091",
publisher = "UBM Medica Healthcare Publications",
number = "4",

}

TY - JOUR

T1 - Evaluation of TGF-α and EGFR expression in oral leukoplakia and oral submucous fibrosis by quantitative immunohistochemistry

AU - Srinivasan, Mythily

AU - Jewell, Scott D.

PY - 2001

Y1 - 2001

N2 - Objective: Oral leukoplakia (OL) and oral submucous fibrosis (OSMF) are clinically distinct preneoplastic states that precede the development of oral squamous cell carcinoma. Recently, attempts are being made to identify specific molecular event(s) as prognostic markers to identify oral precancerous lesions with higher malignant potential. The goal of the present study was to evaluate the expression of EGFR and its ligand TGF-α in OL with dysplasia and OSMF as intermediate markers of malignancy by quantitative immunohistochemistry. Methods: Oral tissues were stained with monoclonal antibodies to TGF-α and EGFR. The results were analyzed with Photoquant image analysis software. Results: The expression of TGF-α and EGFR was upregulated in OL, OSMF and oral squamous cell carcinomas relative to normal oral mucosa. The area and intensity of staining of TGF-α in the proliferative layers (stratum germinativum) increased linearly in OL with mild, moderate and severe dysplasia as compared to control mucosa (p <0.05). EGFR levels increased linearly in the stratum spinosum in OL with increasing degrees of dysplasia (p <0.05). In general, the expression of both proteins in OSMF was similar to that in OL with moderate dysplasia. Conclusions: EGFR and TGF-α represent early markers of malignancy in OL with dysplasia. Quantitative measurement of these proteins may provide intermediate endpoints in prospective chemopreventive trials.

AB - Objective: Oral leukoplakia (OL) and oral submucous fibrosis (OSMF) are clinically distinct preneoplastic states that precede the development of oral squamous cell carcinoma. Recently, attempts are being made to identify specific molecular event(s) as prognostic markers to identify oral precancerous lesions with higher malignant potential. The goal of the present study was to evaluate the expression of EGFR and its ligand TGF-α in OL with dysplasia and OSMF as intermediate markers of malignancy by quantitative immunohistochemistry. Methods: Oral tissues were stained with monoclonal antibodies to TGF-α and EGFR. The results were analyzed with Photoquant image analysis software. Results: The expression of TGF-α and EGFR was upregulated in OL, OSMF and oral squamous cell carcinomas relative to normal oral mucosa. The area and intensity of staining of TGF-α in the proliferative layers (stratum germinativum) increased linearly in OL with mild, moderate and severe dysplasia as compared to control mucosa (p <0.05). EGFR levels increased linearly in the stratum spinosum in OL with increasing degrees of dysplasia (p <0.05). In general, the expression of both proteins in OSMF was similar to that in OL with moderate dysplasia. Conclusions: EGFR and TGF-α represent early markers of malignancy in OL with dysplasia. Quantitative measurement of these proteins may provide intermediate endpoints in prospective chemopreventive trials.

KW - EGFR

KW - Oral epithelial dysplasia

KW - Oral submucous fibrosis

KW - Quantitative image analysis

KW - TGF-α

UR - http://www.scopus.com/inward/record.url?scp=0035205190&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035205190&partnerID=8YFLogxK

U2 - 10.1159/000055335

DO - 10.1159/000055335

M3 - Article

C2 - 11721175

AN - SCOPUS:0035205190

VL - 61

SP - 284

EP - 292

JO - Oncology

JF - Oncology

SN - 0890-9091

IS - 4

ER -